Investing.com - Amgen (NASDAQ:AMGN) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Amgen announced earnings per share of $4.37 on revenue of $6.42B. Analysts polled by Investing.com anticipated EPS of $3.78 on revenue of $6.36B.
Amgen shares are down 10% from the beginning of the year and are trading at $216.48 , down-from-52-week-high.They are under-performing the Dow Jones which is down 7.07% from the start of the year.
Amgen follows other major Healthcare sector earnings this month
Amgen's report follows an earnings beat by J&J on Tuesday, October 13, 2020, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.69 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar